Elated WHO terms dexamethasone clinical trial ‘great news’


The World Health Organisation (WHO) expressed its delight over the initial clinical trials of steroid dexamethasone, which has been termed as a scientific breakthrough in the fight against COVID-19 and the results showing that the drug can be used to save critically ill patients. ?This is the first treatment to be shown to reduce mortality in patients with COVID-19 requiring oxygen or ventilator support,? WHO Director-General Tedros Adhanom Ghebreyesus said in a statement late on Tuesday.